Usefulness of Pretreatment With High-Dose Clopidogrel in Patients Undergoing Primary Angioplasty for ST-Elevation Myocardial Infarction

American Journal of Cardiology

Volumn 104, Issue 4, 2009, Pages 514-518

  Fefer, Paul ^a   Hod, Hanoch ^b   Hammerman, Haim ^c   Segev, Amit ^b   Beinart, Roy ^b   Boyko, Valentina ^b   Behar, Shlomo ^b   Matetzky, Shlomi ^b  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^b SHEBA MEDICAL CENTER   (Israel)

^c RAMBAM MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; CLOPIDOGREL;

ACUTE CORONARY SYNDROME; ADULT; AGED; ANGIOPLASTY; ARTICLE; BLOOD CLOTTING PARAMETERS; CONGESTIVE HEART FAILURE; DIAGNOSTIC VALUE; DOSE TIME EFFECT RELATION; DRUG DOSE COMPARISON; DRUG MEGADOSE; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; ISRAEL; LOADING DRUG DOSE; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; OPTIMAL DRUG DOSE; PERCUTANEOUS CORONARY INTERVENTION; PREMEDICATION; PRIORITY JOURNAL; RECURRENT DISEASE; RISK REDUCTION; ST SEGMENT ELEVATION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STENT THROMBOSIS; TREATMENT OUTCOME;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; COHORT STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PLATELET AGGREGATION INHIBITORS; PREMEDICATION; TICLOPIDINE; TREATMENT OUTCOME;

EID: 67849083515     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2009.04.013     Document Type: Article

References (21)

1. Chen Z.M., Jiang L.X., Chen Y.P., Xie J.X., Pan H.C., Peto R., Collins R., Liu L.S., and COMMIT (ClOpidogrel and Metoprolol in Myocardial Infarction Trial) collaborative group. Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomized placebo-controlled trial. Lancet 366 (2005) 1607-1621
2. Sabatine M.S., Cannon C.P., Gibson C.M., López-Sendón J.L., Montalescot G., Theroux P., Lewis B.S., Murphy S.A., McCabe C.H., and Braunwald E. Clopidogrel as Adjunctive Reperfusion Therapy (CLARITY)-Thrombolysis in Myocardial Infarction (TIMI) 28 Investigators. Effect of clopidogrel pretreatment before percutaneous coronary intervention in patients with ST-elevation myocardial infarction treated with fibrinolytics: the PCI-CLARITY study. JAMA 294 (2005) 1224-1232
3. Lev E.I., Kornowski R., Vaknin-Assa H., Brosh D., Fuchs S., Battler A., and Assali A. Effect of clopidogrel pretreatment on angiographic and clinical outcomes in patients undergoing primary percutaneous coronary intervention for ST-elevation acute myocardial infarction. Am J Cardiol 101 (2008) 435-439
4. Vlaar P.J., Svilaas T., Damman K., de Smet B.J.G.L., Tijssen J.G.P., Hillege H.L., and Zijlstra F. Impact of pretreatment with clopidogrel on initial patency and outcome in patients treated with primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: a systematic review. Circulation 118 (2008) 1828-1836
5. Cutlip D.E., Windecker S., Mehran R., Boam A., Cohen D.J., van Es G.A., Steg P.G., Morel M.A., Mauri L., Vranckx P., McFadden E., Lansky A., Hamon M., Krucoff M.W., Serruys P.W., and Academic Research Consortium. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation 115 (2007) 2344-2351
6. Kabbani S.S., Watkins M.W., Ashikaga T., Terrien E.F., Holoch P.A., Sobel B.E., and Schneider D.J. Platelet reactivity characterized prospectively: a determinant of outcome 90 days after percutaneous coronary intervention. Circulation 104 (2001) 181-186
7. Kabbani S.S., Watkins M.W., Ashikaga T., Terrien E.F., Sobel B.E., and Schneider D.J. Usefulness of platelet reactivity before percutaneous coronary intervention in determining cardiac risk one year later. Am J Cardiol 91 (2003) 876-878
8. Frossard M., Fuchs I., Leitner J.M., Hsieh K., Vlcek M., Losert H., Domanovits H., Schreiber W., Laggner A.N., and Jilma B. Platelet function predicts myocardial damage in patients with acute myocardial infarction. Circulation 110 (2004) 1392-1397
9. Campo G., Valgimigli M., Gemmati D., Percoco G., Tognazzo S., Cicchitelli G., Catozzi L., Malagutti P., Anselmi M., Vassanelli C., Scapoli G., and Ferrari R. Value of platelet reactivity in predicting response to treatment and clinical outcome in patients undergoing primary coronary intervention: insights into the STRATEGY Study. J Am Coll Cardiol 48 (2006) 2178-2185
10. Steinhubl S.R., Talley J.D., Braden G.A., Tcheng J.E., Casterella P.J., Moliterno D.J., Navetta F.I., Berger P.B., Popma J.J., Dangas G., Gallo R., Sane D.C., Saucedo J.F., Jia G., Lincoff A.M., Theroux P., Holmes D.R., Teirstein P.S., and Kereiakes D.J. Point-of-care measured platelet inhibition correlates with a reduced risk of an adverse cardiac event after percutaneous coronary intervention: results of the GOLD (AU-Assessing Ultegra) multicenter study. Circulation 103 (2001) 2572-2578
11. Hochholzer W., Trenk D., Bestehorn H.P., Fischer B., Valina C.M., Ferenc M., Gick M., Caputo A., Büttner H.J., and Neumann F.J. Impact of the degree of peri-interventional platelet inhibition after loading with clopidogrel on early clinical outcome of elective coronary stent placement. J Am Coll Cardiol 48 (2006) 1742-1750
12. Müller I., Seyfarth M., Rüdiger S., Wolf B., Pogatsa-Murray G., Schömig A., and Gawaz M. Effect of a high loading dose of clopidogrel on platelet function in patients undergoing coronary stent placement. Heart 85 (2001) 92-93
13. Angiolillo D.J., Fernández-Ortiz A., Bernardo E., Ramírez C., Sabaté M., Bañuelos C., Hernández-Antolín R., Escaned J., Moreno R., Alfonso F., and Macaya C. High clopidogrel loading dose during coronary stenting: effects on drug response and interindividual variability. Eur Heart J 25 (2004) 1903-1910
14. Gurbel P.A., Bliden K.P., Zaman K.A., Yoho J.A., Hayes K.M., and Tantry U.S. Clopidogrel loading with eptifibatide to arrest the reactivity of platelets: results of the Clopidogrel Loading With Eptifibatide to Arrest the Reactivity of Platelets (CLEAR PLATELETS) study. Circulation 111 (2005) 1153-1159
15. Hochholzer W., Trenk D., Frundi D., Blanke P., Fischer B., Andris K., Bestehorn H.P., Büttner H.J., and Neumann F.J. Time dependence of platelet inhibition after a 600-mg loading dose of clopidogrel in a large, unselected cohort of candidates for percutaneous coronary intervention. Circulation 111 (2005) 2560-2564
16. Montalescot G., Sideris G., Meuleman C., Bal-dit-Sollier C., Lellouche N., Steg P.G., Slama M., Milleron O., Collet J.P., Henry P., Beygui F., Drouet L., and ALBION Trial Investigators. A randomized comparison of high clopidogrel loading doses in patients with non-ST-segment elevation acute coronary syndromes: the ALBION (Assessment of the Best Loading Dose of Clopidogrel to Blunt Platelet Activation, Inflammation and Ongoing Necrosis) trial. J Am Coll Cardiol 48 (2006) 931-938
17. von Beckerath N., Taubert D., Pogatsa-Murray G., Schõmig E., Kastrati A., and Schõmig A. Absorption, metabolization, and antiplatelet effects of 300-, 600-, and 900-mg loading doses of clopidogrel: results of the ISAR-CHOICE (Intracoronary Stenting and Antithrombotic Regimen: Choose Between 3 High Oral Doses for Immediate Clopidogrel Effect) Trial. Circulation 112 (2005) 2946-2950
18. Mehilli J; ISAR Group. BRAVE-3. Abcidimab in patients with AMI undergoing primary PCI after clopidogrel pretreatment. Presented at the Late-Breaking Clinical Trials Session at the SCAI Annual Scientific Sessions in Partnership with American College of Cardiology i2 Summit, Chicago, Illinois, March 2008.
19. Patti G., Colonna G., Pasceri V., Pepe L.L., Montinaro A., and Di Sciascio G. Randomized trial of high loading dose of clopidogrel for reduction of periprocedural myocardial infarction in patients undergoing coronary intervention: results from the ARMYDA-2 (Antiplatelet Therapy for Reduction of Myocardial Damage during Angioplasty) study. Circulation 111 (2005) 2099-2106
20. Lotrionte M., Biondi-Zoccai G.G., Agostoni P., Abbate A., Angiolillo D.J., Valgimigli M., Moretti C., Meliga E., Cuisset T., Alessi M.C., Montalescot G., Collet J.P., Di Sciascio G., Waksman R., Testa L., Sangiorgi G., Laudito A., Trevi G.P., and Sheiban I. Meta-analysis appraising high clopidogrel loading in patients undergoing percutaneous coronary intervention. Am J Cardiol 100 (2007) 1199-1206
21. Sabatine M.S., Hamdalla H.N., Mehta S.R., Fox K.A., Topol E.J., Steinhubl S.R., and Cannon C.P. Efficacy and safety of clopidogrel pretreatment before percutaneous coronary intervention with and without glycoprotein IIb/IIIa inhibitor use. Am Heart J 155 (2008) 910-917